Expression of triple-helical collagen-like products in
View Patent ↗Recombinant bacterial triple-helical collagen-like proteins comprising two or more repetitive sequences of Gly-Xaa-Yaa yielding high-stability polymeric constructs without the need for post-translational modifications and which may incorporate one or more functional domains of biological or structural importance. The polymers are capable of high-yield production for a variety of applications.
1. A recombinant bacterial collagen-like protein structure comprising a formula:
[(Gly-Xaa-Y aa) m -(insert) n ] p
wherein m is between 1 to 200, n is 1, and p is between 2 to 10,
wherein (Gly-Xaa-Yaa) m represents a tandem repeat triple helical domain wherein Xaa and Yaa are independently any natural or unnatural imino or amino acid with the proviso that neither Xaa nor Yaa is a hydroxyproline,
wherein the insert is comprised of 1 to 50 of any imino or amino acids and wherein the insert is a non-triple helical forming peptide sequence,
wherein the tandem repeat triple helical domains have a circular dichroism spectroscopy value of between 0.04 to 0.13 for the ratio of positive peak (about 220 nm) to negative peaks (about 198 nm), and
wherein the collagen-like protein structure is stable at temperatures between 35° C. and 40° C.
2. The collagen-like protein structure of claim 1 , wherein the tandem repeat triple helical domains have a proline content of greater than 19% of all residues in the Xaa and Yaa positions.
3. The collagen-like protein structure of claim 2 , wherein the tandem repeat triple helical domains have a proline content of between 19.5% and 40% of all residues in the Xaa and Yaa positions.
4. The collagen-like protein structure of claim 1 , wherein the tandem repeat triple helical domains have a concentration of charged amino acids of greater than 14% of all residues in the Xaa and Yaa positions.
5. The collagen-like protein structure of claim 1 , wherein the tandem repeat triple helical domains have a concentration of charged amino acids of between 14-35% of all residues in the Xaa and Yaa positions.
6. The collagen-like protein structure of claim 1 , further comprising a non-collagenous domain bound at either an amino terminus end or a carboxy terminus end of the collagen-like protein, which facilitates protein folding of the tandem repeat triple helical domains.
7. The collagen-like protein structure of claim 6 , wherein the non-collagenous domain is SEQ ID NO: 47.
8. The collagen-like protein structure of claim 6 , wherein the non-collagenous domain is SEQ ID NO: 47 and is bound to the protein at the amino terminus end of the collagen-like protein.
9. The recombinantly expressed protein of claim 6 , wherein the non-collagenous domain is SEQ ID NO: 51 and is bound to the protein at the carboxy terminus end of the triple helical domain.
10. The recombinantly expressed protein of claim 6 , wherein the non-collagenous domain is selected from the group consisting of a foldon, a coiled coil sequence, and a C-propeptide.
11. The recombinantly expressed protein of claim 1 , wherein the insert sequence includes at least one non-collagen natural break having a peptide sequence spaced between two glycine residues.
12. The recombinantly expressed protein of claim 11 , wherein the non-collagen natural break is selected from the group consisting of SEQ ID NOs: 12-14, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 50, SEQ ID NO: 65, and combinations thereof.
13. The collagen-like protein structure of claim 1 , wherein the tandem repeat triple-helical domains aggregate at neutral pH.
14. A recombinant bacterial collagen-like protein structure comprising a formula:
[(Gly-Xaa-Y aa) m -(insert) n ] p
and at least one non-collagenous domain bound to the protein structure to at least one of an amino terminus end or a carboxy terminus end of the protein structure,
wherein m is between 1 to 200, n is 1, and p is between 2 to 10,
wherein (Gly-Xaa-Yaa) m represents a tandem repeat triple helical domain wherein Xaa and Yaa are independently any natural or unnatural imino or amino acid with the proviso that neither Xaa nor Yaa is a hydroxyproline,
wherein the insert is comprised of 1 to 50 of any imino or amino acids and wherein the insert is a non-triple helical forming peptide sequence
wherein the tandem repeat triple helical domains have a circular dichroism spectroscopy value of between 0.04 to 0.13 for the ratio of positive peak (about 220 nm) to negative peaks (about 198 nm), and
wherein the non-collagenous domain facilitates protein folding of the tandem repeat triple helical domains, and
wherein the collagen-like protein structure is stable at temperatures between 35° C. and 40° C.
15. The collagen-like protein structure of claim 14 , wherein the tandem repeat triple helical domains have a Proline content of greater than 19% of all residues in the Xaa and Yaa positions.
16. The collagen-like protein structure of claim 15 , wherein the tandem repeat triple helical domains have a Proline content of between 19.5% and 40% of all residues in the Xaa and Yaa positions.
17. The collagen-like protein structure of claim 14 , wherein the tandem repeat triple helical domains have a concentration of charged amino acids of greater than 14% of all residues in the Xaa and Yaa positions.
18. The collagen-like protein structure of claim 14 , wherein the tandem repeat triple helical domains have a concentration of charged amino acids of between 14-35% of all residues in the Xaa and Yaa positions.
19. The collagen-like protein structure of claim 18 , wherein the tandem repeat triple helical domains are stable at temperatures between 35° C. and 40° C. in its native form.
20. The collagen-like protein structure of claim 14 , wherein the non-collagenous domain is SEQ ID NO: 47.1.
21. The collagen-like protein structure of claim 14 , wherein the non-collagenous domain is SEQ ID NO: 47 and is bound to the protein at the amino terminus end of the collagen-like protein.
22. The recombinantly expressed protein of claim 14 , wherein the non-collagenous domain is SEQ ID NO: 51 and is bound to the protein at the carboxy terminus end of the triple helical domain.
23. The recombinantly expressed protein of claim 14 , wherein the non-collagenous domain is selected from the group consisting of a foldon, a coiled coil sequence, and a C-propeptide.
24. The recombinantly expressed protein of claim 14 , wherein the insert sequence includes at least one non-collagen natural break having a peptide sequence spaced between two glycine residues.
25. The recombinantly expressed protein of claim 24 , wherein the non-collagen natural break is selected from the group consisting of SEQ ID NOs: 12-14, SEQ ID NO: 16, SEQ ID NO: 17, SEQ ID NO: 50, SEQ ID NO: 65, and combinations thereof.
26. The collagen-like protein structure of claim 14 , wherein the triple-helical domain aggregates at neutral pH.
27. A method of producing a recombinant collagen-like protein comprising:
(a) inserting nucleic acid sequences encoding a bacterial collagen-like protein into a single nucleic acid vector, said recombinant bacterial collagen-like protein structure comprising a formula:
[(Gly-Xaa-Y aa) m -(insert) n ] p
wherein m is between 1 to 200 n is 1 and is between 2 to 10,
wherein (Gly-Xaa-Yaa) m represents a tandem repeat triple helical domain wherein Xaa and Yaa are independently any natural or unnatural imino or amino acid with the proviso that neither Xaa nor Yaa is a hydroxyproline,
wherein the insert is comprised of 1 to 50 of any imino or amino acids and wherein the insert is a non-triple helical forming peptide sequence;
(b) optionally inserting into said vector a nucleic acid encoding a non-collagenous domain nucleic acid sequence at either or both 5′ or 3′ end of the nucleic acid encoding the bacterial collagen-like protein, which facilitates protein folding of the triple helical domain upon expression;
(c) optionally inserting a sequence tag;
(d) expressing the vector within a micro-organism; and
(e) isolating the bacterial collagen-like protein.
28. The method of claim 27 wherein the nucleic acid vector is a cold-shock vector.
29. The method of claim 27 wherein the nucleic acid sequence is expressed within the micro-organism at temperatures below 37° C.
30. The method of claim 27 wherein the nucleic acid sequence is expressed within the micro-organism at a temperature of about 15° C.